Related Experiment Video
Updated: Oct 15, 2025

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
Published on: May 21, 2018
MicroRNA-216a-5p in lipopolysaccharide-induced endothelial injury
Wenxun Liu1,2, Wenhua Xi1,2, Yan Li1,2
1Department of Anesthesiology, Ningxia Medical University, Yinchuan, Gansu 750004, P.R. China.
Abstract:
MicroRNAs (miRNAs/miRs) are a type of non-coding RNA that are closely associated with disease development and treatment. The present study aimed to investigate the role of miR-216a-5p in lipopolysaccharide (LPS)-induced endothelial injury in vitro. The EdU assay was performed to detect EdU-positive cells, while flow cytometric analysis was performed to detect apoptotic cells. Reverse transcription-quantitative PCR and western blot analyses were performed to detect the expression levels of miR-216a-5p, Toll-like receptor 4 (TLR4), MyD88 and nuclear factor (NF)-κB(p65) and phosphorylated (p)-NF-κB(p65). Furthermore, p-NF-κB(p65) nuclear expression level was detected via cellular immunofluorescence. The dual-luciferase reporter assay was performed to verify the association between miR-216a-5p and TLR4. The results demonstrated that the number of EdU-positive cells significantly decreased, the apoptotic rate significantly increased, and TLR4, MyD88 and NF-κB(p65) mRNA expression levels were significantly upregulated.TLR4, MyD88 and p-NF-κB(p65) protein expression levels were significantly upregulated and p-NF-κB(p65) nuclear concentration was significantly enhanced in the small interfering RNA-miR-216a-5p and LPS groups (P<0.001, respectively) compared with the negative control group. However, the addition of miR-216a-5p significantly increased the number of EdU-positive cells, significantly decreased the apoptotic rate and significantly downregulated the mRNA expression levels of TLR4, MyD88 and NF-κB(p65), as well as the protein expression levels of TLR4, MyD88 and p-NF-κB(p65). In addition, the p-NF-κB(p65) nuclear concentration was significantly decreased in the miR-216a-5p group (P<0.001, respectively) compared with the LPS group. Taken together, the results suggest that overexpression of miR-216a-5p suppresses the effects of LPS induced endothelial injury.
Insights
MicroRNAs (miRNAs) regulate cellular processes. This study shows miR-216a-5p protects against lipopolysaccharide (LPS)-induced endothelial injury by downregulating the TLR4/MyD88/NF-κB pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in various diseases.
- Endothelial injury, often triggered by lipopolysaccharide (LPS), is a critical factor in numerous pathologies.
- The specific role of miR-216a-5p in LPS-induced endothelial dysfunction requires elucidation.
Purpose of the Study:
- To investigate the role and mechanism of miR-216a-5p in lipopolysaccharide (LPS)-induced endothelial injury in vitro.
- To determine the impact of miR-216a-5p on cell proliferation, apoptosis, and the Toll-like receptor 4 (TLR4) signaling pathway.
Main Methods:
- Cell proliferation was assessed using the EdU assay.
- Apoptosis was quantified via flow cytometry.
- Gene and protein expression levels of miR-216a-5p, TLR4, MyD88, and NF-κB(p65) were measured using RT-qPCR and Western blotting.
- Cellular immunofluorescence detected p-NF-κB(p65) nuclear translocation.
- Dual-luciferase reporter assay confirmed the interaction between miR-216a-5p and TLR4.
Main Results:
- LPS treatment significantly decreased cell proliferation and increased apoptosis.
- LPS upregulated the expression of TLR4, MyD88, and NF-κB pathway components.
- Overexpression of miR-216a-5p reversed these effects, promoting cell proliferation, reducing apoptosis, and downregulating the TLR4/MyD88/NF-κB pathway.
- miR-216a-5p directly targets TLR4.
Conclusions:
- miR-216a-5p plays a protective role against LPS-induced endothelial injury.
- The mechanism involves the suppression of the TLR4/MyD88/NF-κB signaling pathway.
- miR-216a-5p represents a potential therapeutic target for endothelial dysfunction.

